The startup provides clinical trial and therapy services that enhance patient engagement and optimize trial processes for pharmaceutical companies. By improving the quality of patient data and fostering trust in trial partnerships, the company addresses inefficiencies in clinical research and patient recruitment.
Funding
$760K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Pharmaceutical companies face challenges in clinical trials, including difficulties in patient recruitment, engagement, and data quality, which can lead to delays and increased costs. Traditional clinical trial models often struggle to reach diverse patient populations and maintain consistent data quality across multiple sites.
Solution
FutureMeds offers clinical trial and therapy services designed to enhance patient engagement and optimize trial processes for pharmaceutical companies and CROs. The company leverages a network of dedicated research sites, experienced investigators, and healthcare provider partnerships to improve patient recruitment and retention. FutureMeds employs a patient-centric approach, focusing on precision recruitment methods, community engagement, and decentralized clinical trial (DCT) solutions to enhance access and convenience for participants. By streamlining trial processes and ensuring quality and compliance through a robust Quality Management System, FutureMeds aims to deliver reliable, efficient trial delivery, resulting in quality data and increased chances of meeting recruitment targets within budget and timeframe.
Target Audience
The primary customers are pharmaceutical companies and contract research organizations (CROs) seeking to improve the efficiency, quality, and diversity of patient participation in clinical trials.
Features
- Independent, fully owned site network with dedicated research teams focused solely on clinical trial delivery
- Precision patient recruitment strategies combining local expertise, healthcare system partnerships, and community engagement
- Decentralized clinical trial (DCT) solutions, including FutureMeds @home, to enhance patient access and real-world data collection
- Access to a diverse patient pool of over 60 million individuals across Europe
- Network of over 220 experienced investigators across various therapy areas
- Partnerships with over 1,300 healthcare providers to expand patient reach and improve referral pathways
- Centrally supported Quality Management System to ensure high trial delivery and data quality with a 48-hour data entry target
- Capabilities across a wide range of therapeutic areas, including cardiovascular, endocrinology, immunology, oncology, and infectious diseases